Home / Cardiologist / HeartLogic™
HE
Paid FEATURED

HeartLogic™

Predictive AI diagnostic for heart failure monitoring.

Snapshot of HeartLogic™
Auto-generated snapshot

The first FDA-approved predictive analytic alert in an implantable device. It uses multiple sensor inputs to predict 70% of heart failure events approximately 34 days in advance.

PROS

  • + FDA-approved and NICE-recommended diagnostic.
  • + Predicts 70% of heart failure events in advance.
  • + Provides a median of 34 days of lead time for clinical intervention.
  • + Uses a multi-sensor algorithm for comprehensive physiological monitoring.

CONS

  • - Requires implantation of a Boston Scientific ICD or CRT-D device.
  • - Does not predict 100% of heart failure events
  • - Access and cost are dependent on medical device coverage and hospital systems.
  • Proactively adjusting heart failure medication
  • early scheduling of follow-up patient visits
  • reducing hospital readmissions for heart failure patients
  • identifying high-risk heart failure patients remotely

SIMILAR TOOLS

Weekly Intel

STAY AHEAD OF THE AI CURVE

Join 10,000+ professionals getting curated AI tool recommendations. No fluff, just actionable value.